×
Hero Background

Vulvar Cancer Companies

ID: MRFR/MED/0914-HCR
85 Pages
Rahul Gotadki
October 2025

The landscape of companies specifically focused on vulvar cancer might be limited compared to broader cancer research and treatment organizations. Vulvar cancer is a relatively rare type of cancer that affects the external female genitalia. However, various pharmaceutical and biotech companies, as well as research institutions, contribute to cancer research and the development of treatments that may be applicable to vulvar cancer.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Vulvar Cancer Market Research Report - Global Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Vulvar Cancer Market

Vulvar Cancer Key Companies

 

Latest Vulvar Cancer Companies Update

 


Roche Holding AG Received FDA approval for their FoundationOne CDx assay, a comprehensive genomic profiling test, to guide personalized treatment decisions in vulvar cancer patients.


Guardant Health Expanded their liquid biopsy testing platform to include vulvar cancer, allowing for non-invasive tumor profiling and potentially improving treatment planning.


Myriad Genetics Developed a new genetic test panel specifically for vulvar cancer, offering a more comprehensive analysis of potential genetic risk factors and personalized treatment options.


Boston Scientific Corporation Launched a new vaginal dilator specifically designed for vulvar cancer survivors, addressing a critical need for post-treatment recovery and intimacy support.


Hologic Introduced their Aptima® HPV test with improved sensitivity for detecting HPV strains associated with vulvar cancer, contributing to earlier diagnosis and prevention efforts.


List of Vulvar Cancer Key Companies in the Market



  • Amgen Inc. (US)

  • Bristol-Myers Squibb Company (US)

  • Celgene Corporation (US)

  • Eli Lilly and Company (US)

  • Hoffmann-La Roche Ltd (Switzerland)

  • Merck & Co.Inc. (US)

  • Novartis AG (Switzerland)

  • Pfizer Inc. (US)

  • GlaxoSmithKline plc (UK)

  • Sanofi (France)

  • and Johnson & Johnson Services Inc. (US)